humans |
46 |
glaucoma |
43 |
diabetic retinopathy |
35 |
intraocular pressure |
35 |
male |
35 |
adult |
32 |
female |
31 |
animals |
25 |
retina |
25 |
neuroprotection |
23 |
cataract |
22 |
prevalence |
22 |
age-related macular degeneration |
21 |
aged |
20 |
middle aged |
19 |
myopia |
19 |
cornea |
18 |
epidemiology |
18 |
hong kong |
18 |
octa |
18 |
optical coherence tomography |
18 |
chinese |
16 |
phacoemulsification |
16 |
risk factors |
16 |
aged, 80 and over |
15 |
visual acuity |
14 |
conjunctiva - virology |
13 |
optical coherence tomography angiography |
13 |
quality of life |
13 |
bronchi - cytology |
12 |
eye diseases |
12 |
influenza a virus, h1n1 subtype - metabolism |
12 |
influenza, human - virology |
12 |
meta-analysis |
12 |
normal tension glaucoma |
12 |
ocular surface disease |
12 |
photodynamic therapy |
12 |
ranibizumab |
12 |
respiratory system - virology |
12 |
retinal detachment |
12 |
silicone oil |
12 |
stroke |
12 |
systematic review |
12 |
visual impairment |
12 |
china |
11 |
cross-sectional studies |
11 |
exophthalmometry values |
11 |
hertel's |
11 |
macular degeneration |
11 |
macular vascular density |
11 |
macular vessel density |
11 |
proptosis |
11 |
retinal ganglion cell |
11 |
selective laser trabeculoplasty |
11 |
swine |
11 |
treatment outcome |
11 |
vitrectomy |
11 |
acute disease |
10 |
adolescent |
10 |
apoptosis |
10 |
asians |
10 |
cataract extraction |
10 |
cataract surgery |
10 |
child |
10 |
conjunctiva |
10 |
covid-19 |
10 |
dry eye |
10 |
emulsification |
10 |
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
medication |
10 |
neurodegeneration |
10 |
organ culture techniques |
10 |
reassortant viruses - isolation & purification |
10 |
respiratory mucosa - virology |
10 |
viral tropism |
10 |
virulence |
10 |
angiogenesis |
9 |
anti-vegf |
9 |
diabetes mellitus |
9 |
inflammation |
9 |
mental health |
9 |
oxidative stress |
9 |
proliferative diabetic retinopathy |
9 |
retinal degeneration |
9 |
screening |
9 |
surgery |
9 |
visual acuity - physiology |
9 |
young adult |
9 |
2009 pandemic h1n1 influenza virus |
8 |
collagen cross-linking |
8 |
endothelin-1 |
8 |
follow-up studies |
8 |
genetic variants |
8 |
genome-wide association studies |
8 |
hong kong - epidemiology |
8 |
imaging |
8 |
innate host responses |
8 |
insr |
8 |
lycium barbarum polysaccharides |
8 |
medical sciences |
8 |
obesity |
8 |
ophthalmology |
8 |
optic neuritis |
8 |
pterygium |
8 |
refraction, ocular - physiology |
8 |
severe cutaneous adverse reactions |
8 |
sight-threatening diabetic retinopathy |
8 |
stevens–johnson syndrome |
8 |
swine influenza virus |
8 |
tomography, optical coherence |
8 |
toxic epidermal necrolysis |
8 |
tropism |
8 |
vitreoretinal surgery |
8 |
animal model |
7 |
anti-inflammatory |
7 |
cell death |
7 |
child, preschool |
7 |
complications |
7 |
cytokines |
7 |
diabetes |
7 |
dry eye disease |
7 |
eyelids |
7 |
infant |
7 |
ischemic stroke |
7 |
macular microcirculation |
7 |
meibomian gland dysfunction |
7 |
molecular sequence data |
7 |
ocular perfusion |
7 |
physical exercise |
7 |
prospective studies |
7 |
refractive error |
7 |
reproducibility of results |
7 |
retinal ganglion cells - pathology |
7 |
safety |
7 |
success |
7 |
verteporfin |
7 |
vessel density |
7 |
visual field |
7 |
acute ocular hypertensive injury |
6 |
amphiphilic |
6 |
asian continental ancestry group |
6 |
bacterial typing techniques |
6 |
bevacizumab |
6 |
bleb leak |
6 |
carotenoids |
6 |
cellular neuroscience |
6 |
chemicals and cas registry numbers |
6 |
corneal biomechanics |
6 |
cystic bleb |
6 |
deep learning |
6 |
endothelial cell count |
6 |
eye |
6 |
eye‐on‐a‐chip |
6 |
half-dose |
6 |
half-fluence |
6 |
hippocampus |
6 |
hypoxia |
6 |
incidence |
6 |
infectious keratitis |
6 |
keratitis - microbiology |
6 |
keratoconus |
6 |
mice |
6 |
microvascular complications |
6 |
molecular neuroscience |
6 |
nanoindentation |
6 |
neovascularization |
6 |
neuroscience |
6 |
pandemic |
6 |
polypoidal choroidal vasculopathy |
6 |
public health |
6 |
retinopathy of prematurity |
6 |
retrospective studies |
6 |
rna, ribosomal, 16s - genetics |
6 |
sequence analysis, dna |
6 |
spherical equivalent |
6 |
tamponade |
6 |
tomography |
6 |
trabeculectomy |
6 |
transcorneal electrical stimulation |
6 |
treatment |
6 |
visually impaired persons - statistics & numerical data |
6 |
3d culturing |
5 |
actinomycetales - isolation & purification |
5 |
actinomycetales infections - diagnosis - microbiology |
5 |
aerosolization |
5 |
aerosols |
5 |
age related macular degeneration |
5 |
arthritis, infectious - microbiology |
5 |
asia |
5 |
astrocyte |
5 |
astrocytes |
5 |
autoimmune encephalitis |
5 |
awareness |
5 |
bacteremia - complications - microbiology |
5 |
biometry |
5 |
blindness |
5 |
blood-brain barrier |
5 |
blood-retinal barrier |
5 |
brain injury |
5 |
cardiac dysfunction |
5 |
cardiac function reserve |
5 |
cellulitis - microbiology |
5 |
childhood glaucoma |
5 |
collagen crosslinking |
5 |
composite hydrogel |
5 |
conjunctival leak |
5 |
cost-effectiveness |
5 |
covid |
5 |
cyclodiode |
5 |
cytomegalovirus retinitis |
5 |
diabetic cardiomyopathy |
5 |
disease progression |
5 |
dna, bacterial |
5 |
dna, bacterial - chemistry - genetics |
5 |
dna, ribosomal |
5 |
dna, ribosomal - chemistry - genetics |
5 |
down syndrome - epidemiology |
5 |
drop instillation |
5 |
droplets |
5 |
dry eye syndrome |
5 |
early identification |
5 |
encapsulated-cell therapy |
5 |
exercise echocardiography |
5 |
eye diseases - epidemiology |
5 |
fibroblasts |
5 |
filtering surgery |
5 |
fishes - microbiology |
5 |
gene deletion |
5 |
glia |
5 |
gout - microbiology |
5 |
health preference |
5 |
health-related quality of life |
5 |
heart disease |
5 |
hemolysis |
5 |
high‐molecular‐weight additive |
5 |
infections |
5 |
intraocular lens |
5 |
ischemia |
5 |
knowledge |
5 |
laser |
5 |
laser therapy |
5 |
lens implantation, intraocular |
5 |
lenses, intraocular |
5 |
limbic encephalitis |
5 |
lycium barbarum |
5 |
menorrhagia |
5 |
mental disorders - epidemiology |
5 |
mice, inbred c57bl |
5 |
myofibroblasts |
5 |
north america |
5 |
ocular disease |
5 |
ocular surface disease index |
5 |
open-angle glaucoma |
5 |
optical coherence |
5 |
optical coherence tomography (oct) |
5 |
paediatric ophthalmology |
5 |
paraneoplastic syndrome |
5 |
patients |
5 |
phylogeny |
5 |
polysaccharides, bacterial - biosynthesis |
5 |
polyunsaturated fatty acid |
5 |
postoperative complications |
5 |
precision eye healthcare |
5 |
primary angle-closure glaucoma |
5 |
primary open-angle glaucoma |
5 |
questionnaires |
5 |
refractive surgery |
5 |
reperfusion injury |
5 |
retinoblastoma |
5 |
rheumatoid arthritis |
5 |
riboflavin |
5 |
saturated fatty acid |
5 |
severity of illness index |
5 |
sjogren syndrome |
5 |
stevens-johnson syndrome |
5 |
streptococcal infections - microbiology |
5 |
streptococcus - classification - isolation & purification - pathogenicity - physiology |
5 |
streptococcus iniae |
5 |
stromal fibrosis |
5 |
survey |
5 |
tear osmolarity |
5 |
thyroid eye disease |
5 |
transforming growth factor-beta 1 |
5 |
vascular factors |
5 |
viscosity |
5 |
vision |
5 |
visual function |
5 |
vitreous substitutes |
5 |
*locomotion |
4 |
24-hour |
4 |
426 apoptosis/cell death |
4 |
530 ganglion cells |
4 |
685 retina |
4 |
accelerated crosslinking |
4 |
activities of daily living/*classification |
4 |
aldehyde reductase - antagonists & inhibitors - deficiency - genetics - physiology |
4 |
aldehyde reductase - deficiency - genetics |
4 |
aldehyde reductase - deficiency - genetics - metabolism |
4 |
alginate |
4 |
alginates - pharmacology |
4 |
alzheimer's disease |
4 |
amyloidosis |
4 |
analysis of variance |
4 |
angle-closure |
4 |
animals, newborn - metabolism |
4 |
antigens, cd31 - genetics |
4 |
apoptosis - drug effects |
4 |
apoptosis - physiology |
4 |
argon laser peripheral iridoplasty |
4 |
astigmatism |
4 |
astrocytes - metabolism |
4 |
atropine |
4 |
blood pressure - physiology |
4 |
blood-brain barrier - drug effects |
4 |
blood-retinal barrier - drug effects - physiopathology |
4 |
blood-retinal barrier - physiopathology |
4 |
blotting, western |
4 |
brain - cytology - metabolism |
4 |
brain chemistry |
4 |
brain chemistry - genetics - physiology |
4 |
brain edema - etiology - pathology - physiopathology - prevention and control |
4 |
brain ischemia - enzymology - metabolism - pathology |
4 |
brain slice |
4 |
cataract - complications |
4 |
cataract extraction - methods |
4 |
cell death - physiology |
4 |
cell division |
4 |
cell encapsulation |
4 |
cell proliferation |
4 |
cell survival |
4 |
central cornea thickness |
4 |
central corneal thickness |
4 |
cerebral infarct |
4 |
cerebral ischemia |
4 |
cerebral palsy/*diagnosis/epidemiology/rehabilitation |
4 |
child health (paediatrics) |
4 |
choroid diseases - diagnosis |
4 |
choroidal neovascularization |
4 |
choroidal thickness |
4 |
classification |
4 |
collagen |
4 |
collagen - pharmacology |
4 |
collagen–alginate composite hydrogel |
4 |
consensual ophthalmotonic reaction |
4 |
corneal collagen crosslinking |
4 |
corneal resurfacing |
4 |
corneal scarring |
4 |
corneal wound healing |
4 |
cortex |
4 |
corvis st |
4 |
coulter counter |
4 |
db/db mouse |
4 |
diabetes mellitus - genetics - physiopathology |
4 |
diabetes mellitus, type 2 - complications - enzymology - metabolism - pathology |
4 |
diabetic macular edema |
4 |
direct ophthalmoscopy |
4 |
disability evaluation |
4 |
disease models, animal |
4 |
disease progress monitoring |
4 |
drug carriers |
4 |
drugs, chinese herbal - pharmacology |
4 |
drugs, chinese herbal - pharmacology - therapeutic use |
4 |
edema |
4 |
electrical phosphene threshold |
4 |
electrical stimulation |
4 |
electroretinography |
4 |
encapsulated cell therapy |
4 |
endophthalmitis |
4 |
endothelin-1 - biosynthesis - genetics |
4 |
endothelium, vascular - cytology - metabolism |
4 |
ex-press |
4 |
express shunt |
4 |
eye disease |
4 |
eye diseases - diagnosis |
4 |
eye disorders |
4 |
eye-on-a-chip |
4 |
fibroblast |
4 |
g-probe |
4 |
gdnf |
4 |
gene expression regulation, enzymologic |
4 |
glaucoma surgery |
4 |
glaucoma, angle-closure |
4 |
glial cell |
4 |
glial cell line-derived neurotrophic factor - secretion |
4 |
glutamic acid - metabolism |
4 |
handheld device |
4 |
health services |
4 |
hek293 cells |
4 |
human keratocytes |
4 |
hydrogel |
4 |
hyperopia |
4 |
hypoxia-ischemia, brain - metabolism |
4 |
imidazolidines - therapeutic use |
4 |
immunohistochemistry |
4 |
l-iditol 2-dehydrogenase - antagonists & inhibitors - genetics - physiology |
4 |
laser coagulation - methods |
4 |
laser light scattering |
4 |
machine learning |
4 |
magnetic resonance imaging |
4 |
measurement |
4 |
medical education |
4 |
meibography |
4 |
mental retardation/*diagnosis/epidemiology |
4 |
mice, mutant strains |
4 |
microencapsulation |
4 |
microglia |
4 |
microsphere |
4 |
microspheres |
4 |
monitoring system |
4 |
mouse |
4 |
müller cells |
4 |
nerve fibers |
4 |
neuroglia |
4 |
neuroglia - metabolism |
4 |
neurologic examination/*statistics & numerical data |
4 |
neuronal apoptosis |
4 |
neurons - drug effects - pathology |
4 |
neuroprotective agents - pharmacology |
4 |
nfκb |
4 |
oct |
4 |
ocular redness |
4 |
open angle glaucoma |
4 |
operative |
4 |
ophthalmology and optometry |
4 |
optic nerve |
4 |
oxidative stress - drug effects |
4 |
papilledema - enzymology - pathology - prevention & control |
4 |
phacoemulsification - methods |
4 |
phacotrabeculectomy |
4 |
pilot projects |
4 |
polymerase chain reaction |
4 |
postoperative complications - prevention & control |
4 |
pregnancy |
4 |
prevention |
4 |
progressive outer retinal necrosis |
4 |
pyrimidines - therapeutic use |
4 |
rap1 |
4 |
rat |
4 |
reconstruction |
4 |
recurrence |
4 |
regeneration |
4 |
renal transplantation |
4 |
reoperation |
4 |
reperfusion |
4 |
reperfusion injury - drug therapy |
4 |
reperfusion injury - enzymology - pathology - prevention & control |
4 |
retina - cytology - enzymology |
4 |
retina - pathology |
4 |
retinal diseases |
4 |
retinal diseases - enzymology - metabolism - pathology |
4 |
retinal diseases - enzymology - pathology - prevention & control |
4 |
retinal nerve fiber layer |
4 |
retinitis pigmentosa |
4 |
rna, messenger - biosynthesis |
4 |
selective laser trabeculplasty |
4 |
self care/classification/*statistics & numerical data |
4 |
silicone oils - administration and dosage - chemistry |
4 |
sorbitol dehydrogenase |
4 |
spectral reconstruction |
4 |
statistics as topic |
4 |
stroke - complications - drug therapy - pathology - physiopathology |
4 |
stroke - enzymology - metabolism - pathology |
4 |
subconjunctival hemorrhage |
4 |
surgical procedures |
4 |
tgfβ1 |
4 |
trans-epithelial crosslinking |
4 |
transgenic mice |
4 |
treatment surgery |
4 |
trends |
4 |
uveitis |
4 |
varicella zoster virus |
4 |
vascular endothelial growth factor |
4 |
vascular endothelial growth factor a - genetics |
4 |
xanthophyll |
4 |
412 age-related macular degeneration |
3 |
416 amacrine cells |
3 |
571 ischemia |
3 |
594 microglia |
3 |
602 muller cells |
3 |
606 neovascularization |
3 |
612 neuroprotection |
3 |
651 proliferation |
3 |
652 proliferative vitreoretinopathy |
3 |
696 retinal glia |
3 |
697 retinal neovascularization |
3 |
698 retinal pigment epithelium |
3 |
703 retinopathy of prematurity |
3 |
737 transplantation |
3 |
762 vitreoretinal surgery |
3 |
764 vitreous substitutes |
3 |
accuracy |
3 |
administration, oral |
3 |
age |
3 |
ahmed glaucoma valve |
3 |
aldehyde reductase - antagonists & inhibitors - genetics - metabolism |
3 |
aldehyde reductase - deficiency |
3 |
aldose reductase |
3 |
algorithms |
3 |
analgesia |
3 |
angle |
3 |
animal models |
3 |
animals, newborn |
3 |
anterior chamber depth |
3 |
anterior segment oct |
3 |
antiglaucoma medication |
3 |
antioxidant |
3 |
antioxidant (2.084) |
3 |
antioxidants - pharmacology |
3 |
aquaporin |
3 |
aquaporin 4 |
3 |
aquaporin 4 - genetics - metabolism |
3 |
aquaporins - biosynthesis |
3 |
artificial intelligence |
3 |
astrocytes - drug effects - physiology |
3 |
astrocytes - metabolism - ultrastructure |
3 |
attention-deficit/hyperactivity disorder |
3 |
autoimmune diseases |
3 |
autoimmune disorders |
3 |
autophagy inhibitors |
3 |
axial length |
3 |
baclofen |
3 |
behavior, animal - physiology |
3 |
best corrected visual acuity |
3 |
beta-galactosidase - analysis |
3 |
biomaterials |
3 |
biosafety |
3 |
blood-brain barrier - physiology |
3 |
blood–brain barrier |
3 |
blotting, northern - methods |
3 |
brain - blood supply - cytology - metabolism - pathology |
3 |
brain - blood supply - pathology |
3 |
brain - pathology |
3 |
brain damage |
3 |
brain development |
3 |
brain edema - chemically induced - physiopathology |
3 |
brain edema - etiology - metabolism |
3 |
brain injuries - metabolism - pathology - prevention & control |
3 |
brain ischemia - metabolism - pathology - prevention & control |
3 |
bullous keratopathy |
3 |
cancer treatment |
3 |
capillaries - physiology |
3 |
carotenoid |
3 |
case-control studies |
3 |
caspase |
3 |
caspase 3 - metabolism |
3 |
cataract - epidemiology |
3 |
cell damage |
3 |
cell death and survival |
3 |
cell hypoxia |
3 |
cell size |
3 |
cell therapy |
3 |
cells, cultured |
3 |
central serous chorioretinopathy |
3 |
childhood myopia |
3 |
children |
3 |
chinese population |
3 |
choroidal neovascularization - diagnosis - drug therapy - microbiology |
3 |
ciliochoroidal detachment |
3 |
clinical applications |
3 |
clinical article |
3 |
clinical practice |
3 |
clinical trial (2.172) |
3 |
clinical trials as topic |
3 |
cohort studies |
3 |
coloring agents |
3 |
combination therapy |
3 |
combined modality therapy |
3 |
conditional |
3 |
confocal scanning laser ophthalmoscopy |
3 |
controlled study |
3 |
conventional glycemic control |
3 |
cornea stromal scarring |
3 |
corneal decompensation |
3 |
corneal donation |
3 |
corneal edema |
3 |
corneal melting |
3 |
corneal thickness |
3 |
coronavirus |
3 |
crosslinking |
3 |
crystallization |
3 |
culture media, serum-free |
3 |
cytoprotection - physiology |
3 |
cytotoxic edema |
3 |
dark agouti rats |
3 |
demyelinating disease |
3 |
determinants |
3 |
diagnosis |
3 |
diagnostic techniques, ophthalmological |
3 |
diet supplementation |
3 |
dietary supplement |
3 |
dimethylpolysiloxanes - chemistry |
3 |
diseases |
3 |
diurnal intraocular pressure fluctuation |
3 |
donor cells |
3 |
double emulsion |
3 |
doxycycline |
3 |
drainage - methods |
3 |
droplet microfluidics |
3 |
drusen |
3 |
east respiratory |
3 |
ef1α |
3 |
eiia-cre |
3 |
electrical stimulation (es) |
3 |
electrical stimulation therapy |
3 |
electroretinographic responses |
3 |
electroretinography: non-clinical |
3 |
embryo, mammalian |
3 |
emulsions |
3 |
encapsulation |
3 |
endogenous endophthalmitis |
3 |
endophthalmitis - diagnosis - drug therapy - microbiology |
3 |
endotamponade |
3 |
endothelin receptor antagonist |
3 |
endothelin receptors |
3 |
endothelin-1 - biosynthesis |
3 |
endothelin-1 - genetics - metabolism |
3 |
endothelin-1 - genetics - metabolism - pharmacology |
3 |
endothelin-2 - genetics - metabolism |
3 |
endothelin-3 |
3 |
endothelin-3 - genetics - metabolism |
3 |
endothelium |
3 |
endothelium, vascular - metabolism - pathology |
3 |
enhanced depth imaging optical coherence tomography |
3 |
enzyme-linked immunosorbent assay |
3 |
epithelial wound healing |
3 |
epithelial-mesenchymal transition |
3 |
epithelium |
3 |
et-1-deficient mice |
3 |
evans blue |
3 |
experimental therapy |
3 |
experimental – laboratory |
3 |
express mini-shunt |
3 |
eye hemorrhage |
3 |
eye infections, bacterial - diagnosis - drug therapy - microbiology |
3 |
eye infections, viral - diagnosis - immunology - therapy |
3 |
eye movements |
3 |
failure |
3 |
filtering bleb |
3 |
fludarabine |
3 |
free radical |
3 |
ganciclovir |
3 |
gene expression regulation |
3 |
gene expression regulation, developmental - physiology |
3 |
gene mutation |
3 |
genes, reporter - genetics |
3 |
genetics |
3 |
genotype |
3 |
gfap |
3 |
glands |
3 |
glaucoma drainage devices |
3 |
glaucoma implants |
3 |
glaucoma, angle-closure - surgery |
3 |
glial fibrillary acidic protein - genetics - metabolism |
3 |
glucose control |
3 |
goniotomy |
3 |
graves’ disease |
3 |
head and neck neoplasms/*surgery |
3 |
healon |
3 |
heavy silicone oil |
3 |
hek cells |
3 |
hematopoietic stem cell transplantation - adverse effects |
3 |
herpes simplex keratitis |
3 |
herpes zoster ophthalmicus - diagnosis - immunology - therapy |
3 |
hippocampus - blood supply - pathology |
3 |
home inspection |
3 |
homeostasis |
3 |
hydrophobic acrylic |
3 |
hypercholesterolemia |
3 |
hypoxia/ischemia |
3 |
image processing, computer-assisted |
3 |
imaging methods (ct, fa, icg, mri, oct, rta, slo, ultrasound) |
3 |
imidazolidines - metabolism |
3 |
immune checkpoint inhibitors |
3 |
immune homeostasis |
3 |
immune-related adverse events |
3 |
immunity |
3 |
immunocompromised host |
3 |
immunosuppression - adverse effects |
3 |
in situ hybridization |
3 |
in situ hybridization - methods |
3 |
in-jury |
3 |
infant, newborn |
3 |
infarct |
3 |
infarction, middle cerebral artery |
3 |
infarction, middle cerebral artery - complications - metabolism - pathology |
3 |
infarction, middle cerebral artery - genetics - metabolism - pathology |
3 |
infection |
3 |
inflammatory eye disease |
3 |
inflammatory pain |
3 |
insulin dependent diabetes mellitus |
3 |
integrases - genetics - metabolism |
3 |
intense glycemic control |
3 |
internal tamponades |
3 |
intestinal microbiota |
3 |
intraocular pressure - drug effects |
3 |
intraocular pressure - physiology |
3 |
intraocular pressure/*physiology |
3 |
intravitreal |
3 |
iris |
3 |
iris - surgery |
3 |
iron - metabolism |
3 |
isoprostanes |
3 |
jugular veins/*surgery |
3 |
klebsiella infections - diagnosis - drug therapy - microbiology |
3 |
knockout mice |
3 |
l-iditol 2-dehydrogenase - genetics - metabolism |
3 |
l-lactate dehydrogenase - secretion |
3 |
lactate dehydrogenase |
3 |
lamp1 |
3 |
lasik |
3 |
lc3 |
3 |
lens |
3 |
leukemia, myeloid, acute - therapy |
3 |
light-triggered drug release |
3 |
lipid peroxidation |
3 |
lipid, atherosclerosis |
3 |
liver abscess - diagnosis - drug therapy - microbiology |
3 |
lutein |
3 |
macroautophagy |
3 |
macula |
3 |
management |
3 |
mcao |
3 |
medicine & public health |
3 |
medulla oblongata - embryology - metabolism |
3 |
melatonin |
3 |
method of cell delivery |
3 |
mice, inbred cba |
3 |
mice, knockout |
3 |
mice, transgenic |
3 |
microbead occlusion |
3 |
middle east |
3 |
minimization |
3 |
mitochondria |
3 |
models, anatomic |
3 |
models, biological |
3 |
monitoring |
3 |
mouse embryo |
3 |
mycoses - drug therapy |
3 |
myelination |
3 |
myopia progression control |
3 |
n-methyl-d-aspartate receptors |
3 |
nanotechnology |
3 |
natural product |
3 |
nd:yag laser |
3 |
neck dissection/*methods |
3 |
necrosis |
3 |
nerve degeneration - genetics - metabolism - pathology |
3 |
nerve fibers - pathology |
3 |
nerve fibers/*pathology |
3 |
nervous system diseases - etiology |
3 |
neurodevelopmental disorder |
3 |
neurogenesis |
3 |
neurologic deficit |
3 |
neurological deficit |
3 |
neuroophthalmology |
3 |
neuroplasticity |
3 |
neuroprotective agents |
3 |
neurotrauma |
3 |
non insulin dependent diabetes mellitus |
3 |
ocular drug delivery |
3 |
ocular hypertension |
3 |
ocular hypertension/etiology |
3 |
ocular stress |
3 |
ocular surface diseases |
3 |
oligodendrocyte |
3 |
omega-6/omega-3 polyunsaturated fatty acid ratio |
3 |
ophthalmic considerations |
3 |
ophthalmic diseases |
3 |
ophthalmic specialty clinics |
3 |
opportunistic infections - diagnosis - immunology - therapy |
3 |
optic disk - anatomy & histology |
3 |
optic disk/*pathology |
3 |
optic nerve head |
3 |
optics and refraction |
3 |
outcome |
3 |
oxygen-induced retinopathy |
3 |
pediatric glaucoma |
3 |
pediatric glaucoma surgery |
3 |
peptide elongation factor 1 - genetics |
3 |
perfluorobutylpentane (f4h5) |
3 |
perfluorocarbon liquid |
3 |
perfluoropropane |
3 |
phacomorphic |
3 |
phacomorphic glaucoma |
3 |
phenotype |
3 |
photoreceptor |
3 |
photoreceptor cells, vertebrate - pathology |
3 |
plateau iris configuration |
3 |
plateau iris syndrome |
3 |
polyol pathway |
3 |
pons - embryology - metabolism |
3 |
posterior chamber |
3 |
postoperative period |
3 |
potential risks |
3 |
pre-emptive |
3 |
predictors |
3 |
primary acute angle closure |
3 |
primary congenital glaucoma |
3 |
programmed cell death |
3 |
propofol |
3 |
public health care system |
3 |
quantitative collection |
3 |
rcts |
3 |
rd10 |
3 |
receptor, endothelin a - antagonists & inhibitors |
3 |
receptor, endothelin b - antagonists & inhibitors |
3 |
receptors, endothelin - genetics - metabolism |
3 |
receptors, transferrin - metabolism |
3 |
recurrent acute angle-closure attack |
3 |
regulated cell death |
3 |
reperfusion injury - metabolism - pathology |
3 |
reperfusion injury - metabolism - pathology - prevention and control |
3 |
research design |
3 |
respiratory control |
3 |
retinal degenerative diseases |
3 |
retinal detachment - pathology |
3 |
retinal detachment - surgery |
3 |
retinal diseases - etiology |
3 |
retinal diseases - metabolism - pathology - prevention and control |
3 |
retinal diseases - surgery |
3 |
retinal ganglion cells |
3 |
retinal ganglion cells - cytology |
3 |
retinal ganglion cells - drug effects - pathology |
3 |
retinal necrosis syndrome, acute - diagnosis - immunology - therapy |
3 |
retinal neovascularization - enzymology - pathology - prevention and control |
3 |
retinal nerve fiber thickness |
3 |
retinal nerve fibre layer |
3 |
retinal neuron |
3 |
retinal neurons |
3 |
retinal thickness |
3 |
retinopathy |
3 |
retinopathy of prematurity - enzymology - pathology - prevention and control |
3 |
reverse transcriptase polymerase chain reaction |
3 |
risk factor |
3 |
rituximab |
3 |
rna, messenger - analysis |
3 |
rna, messenger - metabolism |
3 |
rnfl |
3 |
rubeotic glaucoma |
3 |
saccades - physiology |
3 |
scanning laser polarimetry |
3 |
scleral buckling |
3 |
self-assembly |
3 |
sensitivity and specificity |
3 |
silicone oils - adverse effects |
3 |
silicone oils - chemistry |
3 |
single cell |
3 |
slt |
3 |
smile |
3 |
spectral domain optical coherence tomography |
3 |
specular microscopy |
3 |
stem cell |
3 |
stem cell therapy |
3 |
steroid-induced glaucoma |
3 |
success rate |
3 |
sulfur hexafluoride |
3 |
surgical procedures, minimally invasive |
3 |
sustained drug delivery |
3 |
syndrome |
3 |
systemic treatment |
3 |
target cell types |
3 |
testis - blood supply - metabolism - ultrastructure |
3 |
therapy |
3 |
time factors |
3 |
tomography, x-ray computed |
3 |
tonometry, ocular/methods |
3 |
topical treatment |
3 |
trabeculectomy - methods |
3 |
trabeculotomy |
3 |
traditional chinese medicine (2.592) |
3 |
traditional chinese medicine (tcm) |
3 |
transferrin - metabolism |
3 |
trauma |
3 |
treatment lasers |
3 |
triage |
3 |
triamcinolone acetonide |
3 |
trigonal small molecules |
3 |
true exfoliation |
3 |
tube shunts |
3 |
two-tiered |
3 |
tyrosine - analogs & derivatives - metabolism |
3 |
ulcer |
3 |
up-regulation |
3 |
uveitic glaucoma |
3 |
vasopressin receptor antagonist |
3 |
ventrolateral medulla |
3 |
vessel |
3 |
viral proteins - genetics - metabolism |
3 |
vision disorders |
3 |
visual cortex |
3 |
visual outcome |
3 |
vitreous body - surgery |
3 |
water - metabolism |
3 |
water intoxication |
3 |
0.01% atropine |
2 |
3d bioprinting |
2 |
3d rnfl profile |
2 |
3d-migrated |
2 |
481 cornea |
2 |
abscess - diagnosis - microbiology - surgery |
2 |
acetazolamide - administration and dosage |
2 |
acetazolamide - therapeutic use |
2 |
acute angle-closure glaucoma |
2 |
acute glaucoma |
2 |
acute phacomorphic angle-closure |
2 |
acute primary angle closure |
2 |
acute primary angle-closure |
2 |
administration, topical |
2 |
adolescent health |
2 |
aflibercept |
2 |
age correlation |
2 |
age-related neurodegeneration |
2 |
all-aqueous droplets |
2 |
all-aqueous system |
2 |
amblyopia |
2 |
amino acid sequence |
2 |
anesthesia, local - methods |
2 |
angiography |
2 |
angle closure glaucoma |
2 |
angle-closure glaucoma |
2 |
anterior chamber - anatomy & histology - surgery |
2 |
anterior chamber - anatomy & histology - ultrasonography |
2 |
anterior chamber - metabolism - pathology |
2 |
anterior chamber angle |
2 |
anterior segment optical coherence tomography |
2 |
anthropometry |
2 |
anti-allergic agents |
2 |
anti-bacterial agents - administration & dosage |
2 |
anti-inflammatory agents - therapeutic use |
2 |
antibacterial |
2 |
anticoagulants - administration & dosage - pharmacokinetics - therapeutic use |
2 |
anticonvulsants - adverse effects |
2 |
antidepressive agents - adverse effects |
2 |
antifungal agents - administration & dosage |
2 |
antihypertensive agents - administration & dosage |
2 |
antihypertensive agents - therapeutic use |
2 |
antineoplastic agents - administration & dosage - adverse effects - therapeutic use |
2 |
antivascular endothelial growth factor |
2 |
applications |
2 |
aqueous two-phase system |
2 |
arsenicals - administration & dosage - adverse effects - therapeutic use |
2 |
asian |
2 |
asian continental ancestry group - ethnology |
2 |
assembly |
2 |
autoimmunity |
2 |
axonal regeneration |
2 |
axons - pathology |
2 |
basement membrane - pathology - physiopathology - surgery |
2 |
bioactivity preservation |
2 |
biocompatibility |
2 |
biomechanical properties |
2 |
biomimetic |
2 |
biomolecular assembly |
2 |
birefringence |
2 |
blindness - chemically induced - therapy |
2 |
blindness prevention |
2 |
blood glucose |
2 |
body height |
2 |
both eyes |
2 |
brain ischemia - chemically induced - drug therapy |
2 |
brilliant blue g |
2 |
brimonidine |
2 |
bronchiectasis |
2 |
bronchiectasis - diagnosis - microbiology - surgery |
2 |
calcitriol |
2 |
cataract - complications - therapy |
2 |
cataract barriers |
2 |
cataract extraction - adverse effects - statistics & numerical data |
2 |
cataract screening |
2 |
cattle |
2 |
cell count |
2 |
cell differentiation - physiology |
2 |
cell proliferation - drug effects |
2 |
central nervous system injury |
2 |
central retinal arteriolar equivalent |
2 |
central retinal venular equivalent |
2 |
cerebral blood flow |
2 |
chalazion |
2 |
chickenpox - complications - physiopathology |
2 |
childhood |
2 |
children in hong kong |
2 |
cholinergic antagonists - adverse effects |
2 |
choriocapillaris |
2 |
choroid - blood supply - pathology |
2 |
choroid - pathology |
2 |
choroid diseases - diagnosis - microbiology - surgery |
2 |
choroidal abscess |
2 |
chronic angle closure glaucoma |
2 |
chronic angle-closure glaucoma |
2 |
chronic disease |
2 |
ciliary body - surgery |
2 |
clinic |
2 |
cmv |
2 |
combined treatment |
2 |
community health |
2 |
complement factor h |
2 |
compliance |
2 |
cone outer segment tips |
2 |
contact lenses - microbiology |
2 |